- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 39.18M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $156.89M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $157.02M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $144.12M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $168.63M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $364.85M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $390.17M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $390.31M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $433.29M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $823.14M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $893.29M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $83.24M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $26.96M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 37.74M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$18.6M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $570.32M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $598.73M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.95 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.95 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $131.69M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $19.49M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$36.02M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$29.34M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $127.24M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $61.37M |
| Revenue | Q1 2025 · Mar 31, 2024 | $188.61M |